These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 6930415)
1. Science and health regulation. Kennedy D J Dent Educ; 1980 Aug; 44(8):473-7. PubMed ID: 6930415 [No Abstract] [Full Text] [Related]
2. Science, ethics and economics in FDA decision-making: the legal framework. Cooper RM Food Drug Law J; 2006; 61(4):799-803. PubMed ID: 17180773 [No Abstract] [Full Text] [Related]
5. International lists and regulatory reactions: good science needed. Heckman JH Regul Toxicol Pharmacol; 1994 Dec; 20(3 Pt 2):S190-9. PubMed ID: 7724849 [No Abstract] [Full Text] [Related]
6. Improving the quality of risk assessments in Canada using a principle-based approach. Forristal PM; Wilke DL; McCarty LS Regul Toxicol Pharmacol; 2008 Apr; 50(3):336-44. PubMed ID: 18321623 [TBL] [Abstract][Full Text] [Related]
7. Unmatured science and government regulation. Burger EJ J Toxicol Environ Health; 1976 Nov; 2(2):389-99. PubMed ID: 1011295 [TBL] [Abstract][Full Text] [Related]
8. The public governance of science. Fredrickson DS Man Med; 1978; 3(2):77-88. PubMed ID: 10316648 [No Abstract] [Full Text] [Related]
9. Banning "human cloning": a study in the difficulties of defining science. Greely HT South Calif Interdiscip Law J; 1998; 8(1):131-52. PubMed ID: 15085839 [No Abstract] [Full Text] [Related]
10. Regulating human gene therapy. Areen J West VA Law Rev; 1985; 88(2):153-71. PubMed ID: 11655150 [No Abstract] [Full Text] [Related]
11. Leveraging prior quantitative knowledge to guide drug development decisions and regulatory science recommendations: impact of FDA pharmacometrics during 2004-2006. Wang Y; Bhattaram AV; Jadhav PR; Lesko LJ; Madabushi R; Powell JR; Qiu W; Sun H; Yim DS; Zheng JJ; Gobburu JV J Clin Pharmacol; 2008 Feb; 48(2):146-56. PubMed ID: 18199891 [TBL] [Abstract][Full Text] [Related]
12. Making all clinical trials available for review: any impact on clinical decisions? Smith GH J Am Pharm Assoc (2003); 2005; 45(1):7-8. PubMed ID: 15730109 [No Abstract] [Full Text] [Related]
13. Baboon-to-human transplants: should we proceed? Arnold RM; Dresser R; Hefner P; Offner SK Mak Rounds Health Faith Ethics; 1995 Oct; 1(3):1, 3-4, 8. PubMed ID: 11653222 [No Abstract] [Full Text] [Related]
14. AIDS and adolescents. Hartman RG J Health Care Law Policy; 2004; 7(2):280-315. PubMed ID: 15573442 [No Abstract] [Full Text] [Related]
15. Easing restrictions on minors' abortion rights. O'Keeffe J; Jones JM Issues Sci Technol; 1990; 7(4):74-80. PubMed ID: 11659333 [No Abstract] [Full Text] [Related]
16. Decision-making in the regulation of drugs. Cooper JD Antimicrob Agents Chemother (Bethesda); 1967; 7():33-4. PubMed ID: 5631923 [No Abstract] [Full Text] [Related]
17. Federal actions against plagiarism in research. Price AR J Infor Ethics; 1996; 5(1):34-51. PubMed ID: 11653389 [No Abstract] [Full Text] [Related]
18. Incorporating science into decision-making. Karl HA; Turner CE Science; 2003 May; 300(5624):1370. PubMed ID: 12775819 [No Abstract] [Full Text] [Related]
19. Office of Health Regulation final report recommends more analysis before regulation. Reiss J Health Law Vigil; 1981 Mar; 4(5):7-9. PubMed ID: 10250135 [No Abstract] [Full Text] [Related]
20. Closing the loop: a critical assessment of the role of evaluation in the federal bureaucracy. Grossbard S J Health Hum Resour Adm; 1979 May; 1(4):538-56. PubMed ID: 10242229 [No Abstract] [Full Text] [Related] [Next] [New Search]